Celinda M Kofron

Title: Celinda M Kofron: Innovator in Cardiotoxicity Evaluation

Introduction

Celinda M Kofron is a notable inventor based in Hope, Rhode Island. He has made significant contributions to the field of cardiotoxicity evaluation through his innovative work. His research focuses on developing advanced models that enhance the understanding of heart-related toxic effects of various compounds.

Latest Patents

Kofron holds a patent for the invention titled "Human in vitro cardiotoxicity model - The Cardio-Tox Tissue Engineered Model (TEEM)." This invention provides a robust in vitro model for cardiotoxicity evaluation using three-dimensional (3D) human heart microtissues. It quantifies dose-dependent changes in electromechanical activity, resulting in a comprehensive cardiotoxicity and arrhythmia risk assessment of test compounds. The invention also offers a predictive in vitro screening platform for pro-arrhythmic toxicity testing using human three-dimensional cardiac microtissues. This groundbreaking work enables the screening of environmental and pharmaceutical compounds, chemicals, and toxicants to establish safe human exposure levels. Kofron has 1 patent to his name.

Career Highlights

Throughout his career, Kofron has worked with esteemed institutions such as Rhode Island Hospital and Brown University. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Kofron has collaborated with notable colleagues, including Kareen L K Coulombe and Taeyun Kim. These partnerships have further enriched his research and innovation efforts.

Conclusion

Celinda M Kofron's contributions to cardiotoxicity evaluation through his innovative patent demonstrate his commitment to advancing medical research. His work not only enhances the understanding of heart toxicity but also plays a crucial role in ensuring safe human exposure to various compounds.